Auxilium Pharmaceuticals, Inc. (AUXL) Posts Q2 adj.-EPS of 22c; Terminates Testim Co-Promotion (GSK)
Tweet Send to a Friend
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) reported Q2 EPS of $0.02, $0.05 better than the analyst estimate of ($0.03). Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
